Ultrasensitive allele-specific PCR reveals rare preexisting drug-resistant variants and a large replicating virus population in macaques infected with a simian immunodeficiency virus containing human immunodeficiency virus reverse transcriptase. 2012

Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, USA. boltzv@mail.nih.gov

It has been proposed that most drug-resistant mutants, resulting from a single-nucleotide change, exist at low frequency in human immunodeficiency virus type 1 (HIV-1) and simian immunodeficiency virus (SIV) populations in vivo prior to the initiation of antiretroviral therapy (ART). To test this hypothesis and to investigate the emergence of resistant mutants with drug selection, we developed a new ultrasensitive allele-specific PCR (UsASP) assay, which can detect drug resistance mutations at a frequency of ≥0.001% of the virus population. We applied this assay to plasma samples obtained from macaques infected with an SIV variant containing HIV-1 reverse transcriptase (RT) (RT-simian-human immunodeficiency [SHIV](mne)), before and after they were exposed to a short course of efavirenz (EFV) monotherapy. We detected RT inhibitor (RTI) resistance mutations K65R and M184I but not K103N in 2 of 2 RT-SHIV-infected macaques prior to EFV exposure. After three doses over 4 days of EFV monotherapy, 103N mutations (AAC and AAT) rapidly emerged and increased in the population to levels of ∼20%, indicating that they were present prior to EFV exposure. The rapid increase of 103N mutations from <0.001% to 20% of the viral population indicates that the replicating virus population size in RT-SHIV-infected macaques must be 10(6) or more infected cells per replication cycle.

UI MeSH Term Description Entries
D008254 Macaca nemestrina A species of the genus MACACA which inhabits Malaya, Sumatra, and Borneo. It is one of the most arboreal species of Macaca. The tail is short and untwisted. M. leonina,Macaca nemestrina leonina,Macaca nemestrina pagensis,Macaca nemestrina siberu,Macaca siberu,Monkey, Pig-Tailed,Pagai Macaque,Pig-Tail Macaque,Pig-Tailed Macaque,Pig-Tailed Monkey,M. pagensis,Macaca pagensis,Monkey, Pigtail,Monkey, Pigtailed,Pigtail Macaque,Macaque, Pagai,Macaque, Pig-Tail,Macaque, Pig-Tailed,Macaque, Pigtail,Monkey, Pig Tailed,Pagai Macaques,Pig Tail Macaque,Pig Tailed Macaque,Pig Tailed Monkey,Pig-Tail Macaques,Pig-Tailed Macaques,Pig-Tailed Monkeys,Pigtail Macaques,Pigtail Monkey,Pigtail Monkeys,Pigtailed Monkey,Pigtailed Monkeys
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA

Related Publications

Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
December 2015, Antimicrobial agents and chemotherapy,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
September 2004, Antimicrobial agents and chemotherapy,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
June 2005, Journal of virology,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
February 1997, Antimicrobial agents and chemotherapy,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
April 1993, Journal of virology,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
November 2005, Journal of clinical microbiology,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
April 1995, Biochemistry,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
January 2000, Archives of virology,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
September 1992, Laboratory investigation; a journal of technical methods and pathology,
Valerie F Boltz, and Zandrea Ambrose, and Mary F Kearney, and Wei Shao, and Vineet N Kewalramani, and Frank Maldarelli, and John W Mellors, and John M Coffin
December 1998, Journal of virology,
Copied contents to your clipboard!